Paresma Patel

2.4k citations

20 papers · 1.4k indexed · 1 hit paper · h-index 15

Co-authors: Robert H. Grubbs Myles B. Herbert Koji Endo Benjamin K. Keitz Marcey L. Waters Sara M. Butterfield Gideon M. Blumenthal Richard Pazdur
Topics: Synthetic Organic Chemistry Methods (7 papers)Chemical Synthesis and Analysis (3 papers)Protein Degradation and Inhibitors (3 papers)
Cited by: Organic Chemistry Biomaterials Hematology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Cancer Research
Partner nations: United States Switzerland Italy

In The Last Decade

Paresma Patel

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

2018 252 citations Aviva C. Krauss, Xin Gao et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Paresma Patel

Since Specialization

Citations

This map shows the geographic impact of Paresma Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paresma Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paresma Patel more than expected).

Fields of papers citing papers by Paresma Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paresma Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paresma Patel. The network helps show where Paresma Patel may publish in the future.

Co-authorship network of co-authors of Paresma Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Paresma Patel. A scholar is included among the top collaborators of Paresma Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paresma Patel. Paresma Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype 2019 ·Molecular Cancer Therapeutics ·Yansong Bian,Yaroslav Teper,Lesley A. Mathews Griner,Taylor Aiken,Vivek Shukla,Rajarshi Guha,Paul Shinn,Hong-Wu Xin,Holger Pflicke,Astin S. Powers,Dandan Li,Jian‐kang Jiang,Paresma Patel,Steven A. Rogers,Jeffrey Aubé,Marc Ferrer,Craig J. Thomas,Udo Rudloff	19
2	FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemiabreakdown → 2018 ·Clinical Cancer Research ·Aviva C. Krauss,Xin Gao,Liang Li,Michael L. Manning,Paresma Patel,Wentao Fu,Kumar G. Janoria,Gerlie Gieser,David A. Bateman,Donna Przepiorka,Yuan Li Shen,Stacy S. Shord,Christopher M. Sheth,Anamitro Banerjee,Jiang Liu,Kirsten B. Goldberg,Ann T. Farrell,Gideon M. Blumenthal,Richard Pazdur	252
3	Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Jian‐kang Jiang,Xiuli Huang,Khalida Shamim,Paresma Patel,Arthur Lee,Amy Q. Wang,(unknown),Gregory J. Tawa,Gregory D. Cuny,Paul B. Yu,Wei Zheng,Xin Xu,Philip E.J. Sanderson,(unknown)	19
4	FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer 2018 ·Clinical Cancer Research ·Anand Shah,Erik Bloomquist,Shenghui Tang,Wentao Fu,Youwei Bi,Qi Liu,Jingyu Yu,Ping Zhao,Todd R. Palmby,Kirsten B. Goldberg,(unknown),Paresma Patel,(unknown),Amy Tilley,William F. Pierce,Amna Ibrahim,Gideon M. Blumenthal,Rajeshwari Sridhara,Julia A. Beaver,Richard Pazdur	88
5	Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities 2017 ·ACS Combinatorial Science ·Hao Li,Wei Sun,Xiuli Huang,Xiao Lu,Paresma Patel,(unknown),(unknown),(unknown),Takeshi Tanaka,John C. McKew,Anton Simeonov,Philip E.J. Sanderson,Wei Zheng,Kim C. Williamson,Wenwei Huang	8
6	Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1 2016 ·Cancer Research ·(unknown),David J. FitzGerald,Scott E. Martin,Paresma Patel,Marco Prunotto,Pinar Ormanoglu,Craig J. Thomas,Ira Pastan	15
7	In vitro evaluation of imidazo[4,5-c]quinolin-2-ones as gametocytocidal antimalarial agents 2016 ·Bioorganic & Medicinal Chemistry Letters ·Paresma Patel,Wei Sun,(unknown),Xiuli Huang,Philip E.J. Sanderson,Takeshi Tanaka,John C. McKew,Anton Simeonov,Kim C. Williamson,Wei Zheng,Wenwei Huang	10
8	Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras 2016 ·Oncotarget ·(unknown),Robert W. Robey,Victoria Luchenko,Agnès Basseville,Arup R. Chakraborty,(unknown),Gary T. Pauly,Paresma Patel,Joel P. Schneider,Michael M. Gottesman,Susan E. Bates	12
9	Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α 2015 ·Journal of the American Chemical Society ·Susanna T. S. Chan,Paresma Patel,(unknown),Curtis J. Henrich,Tawnya C. McKee,Andrew K.L. Goey,Kristina M. Cook,William D. Figg,James B. McMahon,Martin J. Schnermann,Kirk R. Gustafson	33
10	Ru-based Z-selective metathesis catalysts with modified cyclometalated carbene ligands 2014 ·Chemical Science ·Sarah M. Bronner,Myles B. Herbert,Paresma Patel,Vanessa M. Marx,Robert H. Grubbs	41
11	Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors 2014 ·Proceedings of the National Academy of Sciences ·Michele Ceribelli,Priscilla N. Kelly,Arthur L. Shaffer,George W. Wright,Wenming Xiao,Yibin Yang,Lesley A. Mathews Griner,Rajarshi Guha,Paul Shinn,Jonathan M. Keller,Dongbo Liu,Paresma Patel,Marc Ferrer,Shivangi Joshi,(unknown),Péter Sandy,Emmanuel Normant,Craig J. Thomas,Louis M. Staudt	144
12	Identification of potent Yes1 kinase inhibitors using a library screening approach 2013 ·Bioorganic & Medicinal Chemistry Letters ·Paresma Patel,Hongmao Sun,Samuel Q. Li,Min Shen,Javed Khan,Craig J. Thomas,Mindy I. Davis	26
13	Correction to Improved Ruthenium Catalysts for Z-Selective Olefin Metathesis 2013 ·Journal of the American Chemical Society ·Benjamin K. Keitz,Koji Endo,Paresma Patel,Myles B. Herbert,Robert H. Grubbs	1
14	Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia 2012 ·Leukemia ·Christopher C. Porter,(unknown),Susan Fosmire,Christy M. Gearheart,Annemie Van der Linden,Dmitry Baturin,Vadym Zaberezhnyy,Paresma Patel,Dexiang Gao,Aik Choon Tan,James DeGregori	74
15	Synthesis and Cell Adhesive Properties of Linear and Cyclic RGD Functionalized Polynorbornene Thin Films 2012 ·Biomacromolecules ·Paresma Patel,(unknown),Ying Y. Lu,Eileen Fong,(unknown),David A. Tirrell,Robert H. Grubbs	58
16	Using EPR To Compare PEG-branch-nitroxide “Bivalent-Brush Polymers” and Traditional PEG Bottle–Brush Polymers: Branching Makes a Difference 2012 ·Macromolecules ·Alan O. Burts,Yongjun Li,Aleksandr V. Zhukhovitskiy,Paresma Patel,Robert H. Grubbs,M. Francesca Ottaviani,Nicholas J. Turro,Jeremiah A. Johnson	48
17	Improved Ruthenium Catalysts for Z-Selective Olefin Metathesis 2011 ·Journal of the American Chemical Society ·Benjamin K. Keitz,Koji Endo,Paresma Patel,Myles B. Herbert,Robert H. Grubbs	340
18	Intramolecular Diels−Alder Reactions of Cyclopropenone Ketals 2010 ·Organic Letters ·Paresma Patel,Dale L. Boger	12
19	Intramolecular [1 + 2] and [3 + 2] Cycloaddition Reactions of Cyclopropenone Ketals 2010 ·Journal of the American Chemical Society ·Paresma Patel,Dale L. Boger	20
20	Contribution of Aromatic Interactions to α-Helix Stability 2002 ·Journal of the American Chemical Society ·Sara M. Butterfield,Paresma Patel,Marcey L. Waters	152

About Paresma Patel

Paresma Patel is a scholar working on Organic Chemistry, Surfaces, Coatings and Films and Biotechnology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Organic Chemistry (560 citations), Biomaterials (189 citations) and Hematology (158 citations). Paresma Patel has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Robert H. Grubbs, Myles B. Herbert, Koji Endo, Benjamin K. Keitz, Marcey L. Waters, Sara M. Butterfield, Gideon M. Blumenthal, Richard Pazdur, Wentao Fu and Kirsten B. Goldberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact